Search - tctmd.com

Displaying 761 - 780 of 1432

Sort: Relevancy | Date

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Statins Reduce Amputations After Lower Extremity Procedures

Jason Kahn

December 30, 2013

News Daily News

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

L.A. McKeown

December 30, 2013

News Daily News

El Preacondicionamiento Contrarrestaría el Aumento Plaquetario secundario a la Ablación RF en el Manejo de la FA

L.A. McKeown

December 30, 2013

News Daily News

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

December 30, 2013

News Daily News

Bivalirudin Lowers Post-PCI Bleeding Risk Across All Renal Dysfunction Categories

December 10, 2013

News Daily News

Second-Generation DES the Better Choice for STEMI Patients

December 09, 2013

News Daily News

Los SLF de 2ª Generación son la Mejor Opción para Pacientes víctimas de STEMI

December 09, 2013

News Daily News

IVUS Guidance Reduces Stent Thrombosis, MACE Compared to Angiography

December 08, 2013

News Daily News

El Guiado mediante IVUS Reduce la Trombosis del STENT y los MACE comparado con la Angiografía

December 08, 2013

News Daily News

Warfarin Offers Poor Protection Against Radial Occlusion After Transradial Angiography

November 26, 2013

News Daily News

Registry: Closure Devices Reduce Vascular Complications After Transfemoral PCI

November 21, 2013

News Daily News

Bioengineered Vessels Appear Safe for Use in Dialysis Patients

November 21, 2013

News Conference News TCT 2013

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

November 06, 2013

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

News Daily News

Findings Support DAPT Duration Longer Than 3 Months in ACS Patients

L.A. McKeown

November 01, 2013

News Conference News TCT 2013

Studies Find Differing Benefits of Platelet, Genotype Testing

October 31, 2013

News Conference News TCT 2013

OPTIMIZE: 3-Month DAPT Safe with ZES

October 31, 2013

Advertisement

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Statins Reduce Amputations After Lower Extremity Procedures

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

El Preacondicionamiento Contrarrestaría el Aumento Plaquetario secundario a la Ablación RF en el Manejo de la FA

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

Bivalirudin Lowers Post-PCI Bleeding Risk Across All Renal Dysfunction Categories

Second-Generation DES the Better Choice for STEMI Patients

Los SLF de 2ª Generación son la Mejor Opción para Pacientes víctimas de STEMI

IVUS Guidance Reduces Stent Thrombosis, MACE Compared to Angiography

El Guiado mediante IVUS Reduce la Trombosis del STENT y los MACE comparado con la Angiografía

Warfarin Offers Poor Protection Against Radial Occlusion After Transradial Angiography

Registry: Closure Devices Reduce Vascular Complications After Transfemoral PCI

Bioengineered Vessels Appear Safe for Use in Dialysis Patients

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Findings Support DAPT Duration Longer Than 3 Months in ACS Patients

Studies Find Differing Benefits of Platelet, Genotype Testing

OPTIMIZE: 3-Month DAPT Safe with ZES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content